08:57 AM EDT, 03/20/2024 (MT Newswires) -- Jeffrey B. Mirviss, EVP&Pres, Periph Intervent, on March 18, 2024, sold 14,506 shares in Boston Scientific ( BSX ) for $963,930. Following the Form 4 filing with the SEC, Mirviss has control over a total of 58,098 shares of the company, with 58,098 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/885725/000122520824004316/xslF345X03/doc4.xml

Price: 67.84, Change: +0.05, Percent Change: +0.08